CS Analytical

CS Analytical now offers in-house USP <87> Biological Reactivity testing, strengthening our comprehensive USP <661.1>/<661.2> programs and enhancing support for drug product and medical device package system compliance.

Following our sold-out October 29th webinar, we’re hosting a dedicated one-hour Live Q&A session to address the volume and variety of questions we received. This open-format event offers an opportunity to receive feedback from our team, who have over a decade of experience with this testing. Any general questions about the testing, or those specific to your container/package system and its plastic materials of construction, are welcome. Our team will be glad to share feedback based on their experience. https://lnkd.in/e5_uY_4j

Live Q&A Session on December 10th - Following our sold-out webinar on October 29th regarding the new USP <661.1> and <661.2> changes, the CS Analytical team received an overwhelming number of specific questions. Because the regulatory changes go into effect on December 1, 2025, we decided to host a dedicated, open-floor Live Q&A Session to ensure no question goes unanswered. Register Now!

Biocompatibility isn’t just a regulatory step—it’s a continuous commitment to patient safety and product quality. USP <87> Biological Reactivity Tests (In Vitro) offer a fast, ethical, and reliable way to evaluate cytotoxicity and guide smarter material decisions early in development. At CS Analytical, we help teams integrate USP <87> into their overall packaging qualification strategy—from characterization through commercial release.

As USP 661.1 and 661.2 regulatory updates approach, plastic additive testing will become more complex—and our team is ready. CS Analytical has officially expanded its capabilities with HPLC and GC systems to enhance our support for USP 661.1 material characterization and plastic additive analysis. This upgrade ensures we can continue to guide clients through the evolving requirements and deliver precise, compliant testing programs for all plastic container and package systems.

🔬 Are Your Packaging Systems Ready for the New USP 661.1 & 661.2 Requirements? The landscape for plastic components used in drug product and medical device container systems is changing — and compliance is no longer optional. With major revisions taking effect on December 1, 2025, it’s critical to understand how these changes impact your products and what steps you need to take now. 📅 Free Webinar: Navigating the Shift – USP 661.1 & 661.2 Compliance by December 2025 🗓️ Date: Wednesday, October 29, 2025 🕚 Time: 11:00 AM – 12:00 PM EST Join us as we break down the new testing requirements, implementation strategies, and actionable steps to ensure your packaging systems remain compliant before the deadline. ✅ Learn how USP 661.1 and 661.2 differ ✅ Understand new testing and material characterization requirements ✅ Build a roadmap to full compliance 👉 Reserve your spot now